Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;315(2):e240281.
doi: 10.1148/radiol.240281.

Radiomic Parenchymal Phenotypes of Breast Texture from Mammography and Association with Risk of Breast Cancer

Affiliations

Radiomic Parenchymal Phenotypes of Breast Texture from Mammography and Association with Risk of Breast Cancer

Stacey J Winham et al. Radiology. 2025 May.

Abstract

Background Parenchymal phenotypes reflect the intrinsic heterogeneity of both tissue structure and distribution on mammograms. Purpose To define parenchymal phenotypes on the basis of radiomic texture features derived from full-field digital mammography (FFDM) in breast screening populations and assess associations of parenchymal phenotypes with future risk of breast cancer and masking (false-negative [FN] findings or interval cancers), beyond breast density, and by race and ethnicity Materials and Methods A two-stage study design included a retrospective cross-sectional study of 30 000 randomly selected women with four-view FFDM (mean age, 57.4 years) and a nested case-control study of 1055 women with invasive breast cancer (151 Black and 893 White women) matched to 2764 women without breast cancer (411 Black and 2345 White women) (mean age, 60.4 years) sampled from April 2008 to September 2019 from three diverse breast screening practices. Radiomic features (n = 390) were extracted and standardized using an automated pipeline and adjusted for age and practice. Variation was classified using hierarchical clustering and principal component (PC) analysis. The resulting clusters and PCs were examined for association with invasive breast cancer risk, FN findings on mammograms, and symptomatic interval cancers beyond radiologist-reported Breast Imaging Reporting and Data System (BI-RADS) breast density using conditional logistic regression and likelihood ratio tests. Discrimination for breast cancer was assessed with area under the receiver operating characteristic curve (AUC). Results Six clusters and six PCs were defined, replicated, and associated with a higher risk of invasive breast cancer (P = .01 and P < .001, respectively) after adjustment for age, body mass index (calculated as weight in kilograms divided by height in meters squared), and BI-RADS breast density. PCs showed similar associations among Black and White women (P = .23). PCs were also positively associated with FN findings (P = .004) and symptomatic interval cancers (P = .006). AUC improved for all breast cancer end points when incorporating PCs, with the greatest improvement shown in prediction of FN findings (AUC with vs without PCs, 0.73 [95% CI: 0.68, 0.78] vs 0.66 [95% CI: 0.61, 0.71] , respectively; P = .004) and symptomatic interval cancers (AUC with vs without PCs, 0.77 [95% CI: 0.71, 0.82] vs 0.68 [95% CI: 0.62, 0.74], respectively; P = .006). Conclusion Parenchymal phenotypes based on radiomic features extracted from FFDM were associated with a higher risk of invasive breast cancer, specifically for FN findings and symptomatic interval cancer. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Mesurolle and El Khoury in this issue.

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflicts of interest: S.J.W. No relevant relationships. A.M.M. No relevant relationships. C.G.S. No relevant relationships. A.G. Supported by a research contract from Whiterabbit AI. H.H. No relevant relationships. A.D.N. No relevant relationships. W.C.M. No relevant relationships. L.P. No relevant relationships. M.R.J. No relevant relationships. R.J.A. Several U.S. patents and patent applications jointly assigned to Real Time Tomography and the University of Pennsylvania. A.D.A.M. AI4Imaging invited lecture; patents planned, issued, and pending; member of the Scientific Advisory Board for Real Time Tomography; stock/stock options in Real Time Tomography. E.A.C. No relevant relationships. K.R.B. No relevant relationships. E.F.C. Grants or contracts from iCAD, OM1, Hologic; consulting fees from iCAD, Hologic; payment for lectures from Medality; support for meetings from NCoBC, Hologic; participation on a DataSafety Monitoring Board for iCAD, Hologic; past president, board member for Society of Breast Imaging, National Cancer Consortium Network Committee on Breast Cancer Screening and Diagnosis, American Joint Commission on Cancer. K.M.K. No relevant relationships. D.K. Research grants to author institution from Genmab, iCAD, Calico, Hologic. C.M.V. No relevant relationships.

References

    1. Sprague BL , Gangnon RE , Burt V , et al. . Prevalence of mammographically dense breasts in the United States . J Natl Cancer Inst 2014. ; 106 ( 10 ): dju255 . - PMC - PubMed
    1. Kerlikowske K , Scott CG , Mahmoudzadeh AP , et al. . Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study . Ann Intern Med 2018. ; 168 ( 11 ): 757 – 765 . - PMC - PubMed
    1. Gard CC , Tice JA , Miglioretti DL , et al. . Extending the Breast Cancer Surveillance Consortium Model of Invasive Breast Cancer . J Clin Oncol 2024. ; 42 ( 7 ): 779 – 789 . - PMC - PubMed
    1. Lee A , Mavaddat N , Wilcox AN , et al. . BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors . Genet Med 2019. ; 21 ( 8 ): 1708 – 1718 . [Published correction appears in Genet Med 2019;21(6):1462.] - PMC - PubMed
    1. FDA Updates Mammography Regulations to Require Reporting of Breast Density Information and Enhance Facility Oversight . U.S. Food & Drug Administration . https://www.fda.gov/news-events/press-announcements/fda-updates-mammogra.... Published March 9, 2023. Accessed May 2, 2024 .

LinkOut - more resources